These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32555264)

  • 1. The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
    Wu T; Qu PR; Zhang S; Li SW; Zhang J; Wang B; Liu P; Li CD; Zhao F
    Sci Rep; 2020 Jun; 10(1):9769. PubMed ID: 32555264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebellopontine angle medulloblastoma with extensive nodularity in a child: case report and review of the literature.
    Noiphithak R; Yindeedej V; Thamwongskul C
    Childs Nerv Syst; 2017 May; 33(5):839-842. PubMed ID: 28013334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
    Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
    BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma.
    Zhao F; Li C; Zhou Q; Qu P; Wang B; Wang X; Zhang S; Wang X; Zhao C; Zhang J; Luo L; Ai L; Xu L; Liu P
    J Neurooncol; 2017 Nov; 135(2):353-360. PubMed ID: 28808827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and outcomes of medulloblastoma in adults.
    Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
    Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
    Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO).
    Esbah O; Demirci U; Dane F; Gunaydsin Y; Ozdemir N; Siyar Ekinci A; Kodaz H; Yazilitas D; Rzayev R; Guney Y; Seker M; Uysal M; Inal A; Bilici A; Benekli M; Oksuzoglu B; Buyukberber S
    J BUON; 2016; 21(2):456-60. PubMed ID: 27273958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medulloblastoma: Distinctive Histo-Molecular Correlation with Clinical Profile, Radiologic Characteristics, and Surgical Outcome.
    Narayan V; Sugur H; Jaiswal J; Arvinda HR; Arivazhagan A; Somanna S; Santosh V
    Pediatr Neurosurg; 2019; 54(5):329-340. PubMed ID: 31480064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
    von Bueren AO; von Hoff K; Pietsch T; Gerber NU; Warmuth-Metz M; Deinlein F; Zwiener I; Faldum A; Fleischhack G; Benesch M; Krauss J; Kuehl J; Kortmann RD; Rutkowski S
    Neuro Oncol; 2011 Jun; 13(6):669-79. PubMed ID: 21636711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
    Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P
    J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
    Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
    J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
    Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
    Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medulloblastoma in adults : A retrospective single institution analysis.
    Hadi I; Roengvoraphoj O; Niyazi M; Roeder F; Schüller U; Belka C; Nachbichler SB
    Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Classification of Medulloblastoma.
    Kijima N; Kanemura Y
    Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.
    Lafay-Cousin L; Smith A; Chi SN; Wells E; Madden J; Margol A; Ramaswamy V; Finlay J; Taylor MD; Dhall G; Strother D; Kieran MW; Foreman NK; Packer RJ; Bouffet E
    Pediatr Blood Cancer; 2016 Sep; 63(9):1527-34. PubMed ID: 27145464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma in adults: an analysis of clinico-pathological, molecular and treatment factors.
    Franchino F; Morra I; Forni M; Bertero L; Zanini C; Roveta F; Ricardi U; Mantovani C; Carpaneto A; Migliore E; Pellerino A; Ferrio F; Cassoni P; Garbossa D; Soffietti R; Rudà R
    J Neurosurg Sci; 2024 Jun; 68(3):260-269. PubMed ID: 34763393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas.
    Teo WY; Elghetany MT; Shen J; Man TK; Li X; Chintagumpala M; Su JM; Dauser R; Whitehead W; Adesina AM; Lau CC
    J Neurooncol; 2014 Nov; 120(2):293-301. PubMed ID: 25115738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.